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A B S T R A C T
Hyper IgM (HIGM) syndromes are a complex of primary immunodeficiency disorders. A 4-years-old boy
with recurrent fever and chills, dyspnea, sort throat for a month was admitted to emergency department.
In the current case, whole exome sequencing followed by Sanger sequencing were employed in order to
screen probable functional mutations. Molecular analysis revealed a functional mutation across the
CD40L gene (NM_000074: exon5: c.T464C) resulted in amino acid change p.L155P attributed to X-linked
hyper IgM syndrome. The findings of the current study signify the critical role of microbial infection as
well as XHIGM screening, particularly in those children cases with respiratory symptoms.




Hyper IgM (HIGM) syndromes are a complex of primary
immunodeficiency disorders that was firstly defined by Burtin and
Rosen at the early of 1960 decade [1]. HIGM is resulting from
mutations trough a number of genes that lead to immunoglobulin
class switch recombination [2]. Patients who carry the mutations,
mostly present normal or elevated levels of IgM and suffer from
deficiency of IgG, IgA and IgE. Until now, mutation in couple of
genes responsible for this disorder has been characterized
[3]. According to recent classification, HIGM can be grouped into
8 separate genetically classes. However, damaging mutation in
CD40 ligand (CD40L, CD154) gene is known as the most common
X-linked HIGM and covers about 65–70% of HIGM cases [4,5].
It seems that most of HIGM patients suffer from X-linked
damaging mutation in CD40L gene would lead to malfunction
of activated T cells [6]. Although some available techniques likeAbbreviations: HIGM, Hyper IgM; CD40L, CD40 ligand; WES, whole exome sequencing;
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protein [3,7], most of them are not available in diagnostic Labs,
particularly in developing countries. Therefore, it seems that the
actual number of HIGM cases due to CD40L deficiency is
underestimated.
HIGM patients naturally are more prone to upper and lower
respiratory tract infection not only resulting from primary
infection due to Pneumocystis jiroveci, but also secondary local
or systematic opportunistic infections by fungi, bacteria and
parasites [1,6]. There are strong evidences, showing increased rate
of broad spectrum of malignancy (such as hepatocellular carcino-
ma, GI tract neoplasms and neuroendocrine carcinoma), autoim-
mune disorders and intermittent/persistent neutropenia among
HIGM patients [6]. In the current study, mutation of CD40L gene
related to HIGM was reported from a 4-years-old boy who suffered
from pulmonary complications. To our knowledge, this is the first
case of mutation of CD40L gene responsible for XHIGM in Iran. PAP, pulmonary alveolar proteinosis; PJP, P. jiroveci pneumonia.
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Table 2
Flowcytometric values of lymphocyte’s CD markers of the patient.
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2.1. Clinical features
A 4-years-old boy with recurrent fever and chills, dyspnea, sort
throat for a month with history of antibiotic therapy was admitted
to the emergency department. He had history of recurrent sino-
respiratory symptoms and cold, approximately every month with
no sufficient responses to antibiotic therapy. The child had watery
discharges from his eyes and nose, cough and history of allergic
symptoms particularly in autumn. He has had dysphonia and
anxiety during recent two years. Diagnostic test for Mycobacterium
tuberculosis was prescribed and done that the result was negative.
There was no history of gastrointestinal disorders despite
dysphagia and slight losing weight during the last 2 months. The
pregnancyofhismotherwasnormalandhewasbornafteracesarean.
All the routine vaccines were received without any notable
complication. Antibody response to tetanus, diphtheria and pertussis
vaccines was evaluated that the levels of them were low. His parents
had far familymarriage and his mother’sbrother was dead because of
pneumonia when he was 1-year-old. After physical examinations,
pharynx was slightly erythemic with tumescent tonsils but without
exudate. Auscultation of lungs showed no moist rales, despite rough
breath sound. Abdominal examination and percussion revealed light
distention. There was no organomegaly and mass.
Laboratory findings were: white blood cell (WBC)
2.01 mm  1000 mm with cell differentiation segment: 5.5%,
lymphocyte: 57.7% and monocyte: 35.8%; red blood cell (RBC):
4.65 mm  106 mm; Platelet: 526 mm  1000 mm; Hb: 9.8 g/dL;
Hct: 28.9 mm; MCV: 62.2 fL; MCH: 21.1 Pgm; MCHC: 33.9; RDW-
CV: 15.7; PDW: 8.9 fL; MPV: 8.5 fL; ESR: 80 mm/h; RBC morphol-
ogy was microcytic 1+ and hypochromic 1+. C-reactive protein was
evaluated using serological test and showed 12 mg/L. Complement
C3 and C4 were 2.68 g/L and 0.20 g/L, respectively. Serum level of
IgA was 0.3 g/L, IgG >1.8 g/L, IgE <0.1 IU/L, while the level of IgM
was significantly high and more than 4.6 g/L (Table 1). In this case
neutropenia was observed that was episodic; therefore, one dose
GCSF was described. The IgA and IgG to Toxoplasma gondii were
evaluated using ELISA and were negative. PPD test for tuberculosis
(TB) was negative. In order to assess the infectivity with P. jiroveci,Table 1
Hematological ranges of the patient in comparison with normal ranges.
Parameters Ranges Reference ranges
Red blood cell count (1012/L) 4.65 4.5–6.3
Hemoglobin (gm/dL) 9.8 14–18
Haematocrit (%) 38.9 39–52
MCV (fl) 62.2 77–97
MCHC (gm/dL) 33.9 32–36
MCH (Pgm) 21.1 26–32
White blood cell count (109/L) 2.01 4–10
Segment (%) 5.5 40–80
Lymphocytes (%) 57.7 20–40
Monocytes (%) 36.8 2–10
Platelet (109/L) 526 140–440
C reactive protein (mg/L) 12 0–6
Serum level of immunoglobulina
IgA (g/L) 0.3 0.27–1.95
IgG (g/L) >1.8 5.04–14.64
IgE (IU/L) <0.1 0.02–3.07




Abbreviations: MCV, mean corpuscular volume; MCHC, mean corpuscular
hemoglobin concentration; MCH: mean corpuscular hemoglobin.
a Reference range of immunoglobulins are mentioned based on normal range for
age 4–6 years.
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the presence of specific fragment for P. jiroveci was tested using
PCR that the result was negative. Furthermore, In this case,
presence of CD40L had to demonstrate using flow cytometry that
because of some limitations in order to provide laboratory kits,
performing this test was not possible. However, some other CD
markers were assessed (Table 2).
Chest radiography was applied and showed several reticulo-
nodular infiltrations in lower 5.5 mm zone of each lobes and left
hilum (Fig. 1).
The current study was approved by the Ethic Committee of Iran
University of Medical Sciences. An informed consent was filled by
parents of the patient for further molecular tests. For this purpose,
peripheral blood was collected (EDTA-coagulated) from the child.
The genomic DNA was extracted, and mono whole exomeFig. 1. Chest X-ray showed reticulonodular infiltrations in the lobes and left hilum
of the patient.
Fig. 2. Polymorphism analysis of patient and his mother and father. Father had
normal sequence while molecular analysis showed that patient’s mother carries
heterozygote mutation (T and C).
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direct Sanger sequencing were carried out (Fig. 2).
Molecular analysis revealed mutation in the CD40L gene
(NM_000074: exon5: c.T464C) that was led to amino acid change
p.L155P, which has been reported as cause of hyper IgM syndrome.
3. Discussion
HIGM is a rare immunity disorder resulting from mutation in
the CD40L gene. The patients often are known with normal or high
level of IgM and low level of other class of immunoglobulins. These
patients are more susceptible to opportunistic infections as well as
malignancy [8,9]. This is the first study describing a case of HIGM
with new mutation in CD40L gene in Iran.
Our patient represented low to normal level of IgA, IgG and IgE, in
spite of significant elevated level of IgM. Until now, several cases of
deficiency in CD 27 + memory B cell producing IgM and IgD in
peripheral blood have been described who suffered from HIGM.
These classical features were previously reported in HIGM cases from
all over the world [10,11]. However, long-term antigen simulation
due to malfunction of T cells and abnormal development of B cells
was proposed as the main reason of elevation of level of IgM [12].
Susceptibility to opportunistic infections due to malfunction of
T cell and abnormal development of memory B cells are considered
as the most important concern of physicians [4,13]. Together with
lack/reduction of expression of CD40L in the majority cases of
HIGM, CD40L malfunction is frequently reported from HIGM
patients [3,6,7]. However, almost 20% of patients who suffer from
XHIGM die before 25 years of old due to P. jiroveci pneumonia (PJP)
and liver diseases [1].
In the current case, although laboratory tests for opportunistic
infection like P. jiroveci were negative; more likely, there was no
probability of respiratory symptoms due to pulmonary alveolar
proteinosis (PAP). In this study, PAP was mentioned as differential
diagnosis and pediatric pulmonologist did not advise BAL to
demonstrate PAP. Based on the pathology results, PAP is usually
categorized into three types including: (1) congenital, (2) autoimmune
and (3) secondary. The pivotal role of CD40 ligand for activation of
macrophages was established [14] that indicated macrophage
dysfunctionas themain causeof PAP[15].Ontheother hand,mutation
inCD40Lgenecanleadtomalfunctioninactivationofmacrophagesthat
catabolize surfactant within alveoli results in PAP [16].
In the current study, although the main causative agent of
respiratory symptoms was not characterized, concerning the lack
of strong evidences of PAP and elevated level of CRP, it seems that
the symptoms may be related to microbial agents that became
opportunistic due to immunodeficiency resulting from functional
mutation in CD40L gene.
In this case, mutation in CD40L gene (NM_000074: exon5:
c.T464C) was determined by WES and described as the reason of
XHIGM. However, although flow-cytometry is able to determine the
functionality of CD40L, WES together with available sequencing
approaches can provide deep screen of genes that are responsible for
XHIGM. This mutation was introduced for the first time as a null
mutation [17]. After that Prasad showed this mutation from a
patient with XHIGM in Australia [18]. Nevertheless, the cases of
XHIGM who carry this mutation are very rare. However, our case is
the third XHIGM patient who had this functional mutation. Prasad
and colleagues represented 11 cases with phenotypic features
caused by XHIGM. In accordance with this study, in our case,
mutation c.T464C in exon5 was the reason of XHIGM.
Nevertheless, as mentioned above, it seems that despite the
precise follow up of these patients, most of HIGM patients do not
survive until the second decades of their life [1]. Importantly,
hematopoietic stem cell transplantation (HSCT) has recently intro-Please cite this article in press as: Torabizadeh M, et al. X-linked hyp
very rare case of functional mutation in CD40L gene in Iran. Curr Res duced as a potential treatment of these patients. However, it is well-
established that this kind of treatment has more suitable outcome,
particularly after transplantation from a full matched donor [19].
This is the first study in Iran representing mutation in exon5 of
the CD40L gene responsible for phenotypic features in XHIGM
patient. In the other hand, XHIGM can lead to immunodeficiency
that makes human body prone to infection.
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